Multistep Oncogenesis of Adult T-cell Leukemia/ Lymphoma and Significance of Carbon Anhydrase IX Activated via NF-κB and PI3K | Chapter 2 | Research Advances in Microbiology and Biotechnology Vol. 7

 The objective concerning this review is to analyze the multistep oncogenesis of adult T-cell leukemia/lymphoma (ATL). Human T-container leukemia virus type 1 (HTLV-1) is a causative power of adult ATL. Both ATL and HTLV-1-associated myelopathy (HAM) are began by the type C RNA retrovirus popular as the HTLV-1. It has remained a secret as to reason the HTLV-1-derived proteins may not have performed significant acts in the conclusion of ATL's oncogenesis. Oncogenic processes of ATL are very complicated, and skilled is an enigma that the HTLV-1-derivative proteins Tax and HBZ may not play major acts in completion of allure oncogenesis. Tax activates several point or direct at a goal genes and molecules all along the early polyclonal stage, but HBZ regulates and restricts Tax and its actions all the while the intermediate stage. Additional oncogenic actions in host cells complete the oncogenesis of ATL at the monoclonal stage. In particular, the basic factor kappa B (NF-κB)/hypoxia involving reasoning from facts factor (HIF)/element anhydrase IX (CA9) axis and the phosphatidylinositol 3-kinase (PI3K)/HIF/CA9 axis play essential functions in ATL oncogenesis. The in vitro exploratory studies with CA9 inhibitors again present new therapeutic approaches for medicating ATL.

Author(s) Details:

Mitsuru Sakitani,
Institute CCC, Kobe, Hyogo, 651-2242, Japan.

Please see the link here: https://stm.bookpi.org/RAMB-V7/article/view/12009

Metformin as an Adjuvant Therapy Attenuates Dextran Sulphate Sodium-induced Acute Colitis in Rats: A Recent Study | Chapter 3 | Technological Innovation in Pharmaceutical Research Vol. 3

 The goal of this study is to see if patients with inflammatory bowel diseases (IBDs) are resistant to routine treatment. Immunosuppressive medications like sirolimus (SIR) and tacrolimus (TAC) have been proven to work. However, they have adverse effects that limit their use. Metformin (MET) is an anti-diabetic drug. medication, having anti-inflammatory properties that are promising. As a result, the goal of this research was to confirm the effect of the In the treatment of experimentally produced pain, concurrent administration of MET with SIR or TAC colitis is a disease that affects the digestive system. The Dextran sulphate (DSS) induced colitis model was used in this study.

Methodology: For 9 days, colitis was induced by giving 5 percent DSS in water twice a day via oral gavage. MET 200 mg/kg can be used alone or in conjunction with SIR. On day 7, 1 mg/kg or TAC 1 mg/kg was begun and continued for a total of 12 days. After that, histological and immunohistochemical staining of distal colon tissues was performed. The levels of pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-), interleukin (IL)-1, IL-6, and IL-17A were then evaluated in tissue homogenates. The effects of DSS and the levels of all proinflammatory cytokines were dramatically reduced by MET, SIR, or TAC. Furthermore, MET enhances the effects of SIR and TAC.

Conclusion: When it came to DSS-induced colitis, MET exhibited a significant anti-inflammatory effect. As a result, it could be a viable adjuvant therapy for IBD management. Inhibition of NF-B activation was one of the mechanisms behind the impact. This study can be utilized as a foundation for pilot clinical trials to examine the effect of MET on IBD, given the size of its efficacy and its safety profile. The findings of this study, however, need to be further confirmed and translated into clinical consequences.

Author (s) Details

Rania M. Magadmi
Pharmacology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Fahad H. Aljahdali
Pharmacology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia and Compliance Management at Directorate of Health Affairs in Jeddah City, Jeddah, Saudi Arabia.

Mustafa Alsawy
Department of Histology and Cytology, Faculty of Medicine, Al-Azhar University, Egypt.

Ahmed S. Ali
Pharmacology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia and Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Egypt.

Fatemah O. Kamel
Pharmacology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

View Book :- https://stm.bookpi.org/TIPR-V3/article/view/1146

Delphinol®, a Delphinidin-Enriched Maqui Berry Extract, Improves Bone Metabolism through NF-kB Inactivation and Protects against Bone Loss in Osteopenic Mouse Models | Chapter 8 | Trends in Pharmaceutical Research and Development Vol. 6

 Delphinidin, one of the most abundant anthocyanidins found in vegetables and berry fruits, has been reported to inhibit the formation of osteoclasts from RAW264.7 cells and prevent bone loss in osteoporosis mouse models. We investigated whether a delphinidin glycoside-enriched maqui berry extract (MBE, Delphinol®) exhibits beneficial effects on bone metabolism both in vitro and in vivo to further support the bone protective effects of delphinidin. By upregulating bone morphogenetic protein 2 (Bmp2), runt-related transcription factor 2 (Runx2), osterix (Osx), osteocalcin (Ocn), and matrix extracellular phosphoglycoprotein (Mepe) mRNA, Delphinol® stimulated the osteoblastic differentiation of MC3T3-E1 cells, as demonstrated by increased mineralized nodule formation and increased osteoblastic marker alkaline phosphatase activity. Immunostaining and immunoprecipitation assays showed that by functioning as a superoxide anion/peroxynitrite scavenger in MC3T3-E1 cells, Delphinol ® inhibited NF-aB nuclear translocation. Delphinol® simultaneously prevented both osteoclastogenesis in primary bone marrow macrophages and pit formation on dentine slices by matured osteoclasts. Microcomputed tomography (micro-CT) and femoral bone histomorphometry analysis showed that regular MBE ingestion significantly increased BV/TV (ratio of bone volume to tissue volume), Tb.Th (trabecular thickness), Tb.N (trabecular number), N.Nd/N.Tm (node to terminal ratio), OV/TV (ratio of osteoid volume to tissue volume), BFR/TV (ratio of bone formation to tissue volume), and signified BFR/TV (rate of bone formation to tissue volume) (trabecular separation), Compared to the vehicle controls in the osteopenic mouse models, ES/BS (ratio of eroded surface to bone surface) and N.Oc/BS (number of osteoclasts per unit of bone surface). These results indicate that by not only inhibiting bone resorption but also promoting bone development, Delphinol® may be a promising natural agent for the prevention of bone loss in osteopenic conditions.

Author (s) Details

Keiko Suzuki
Department of Pharmacology, School of Dentistry, Showa University, Tokyo 142-8555, Japan.

Masahiro Nagaoka
Department of Pharmacology, School of Dentistry, Ohu University, Fukushima 963-8611, Japan.

Shumpei Niida
Research Institute, National Center for Geriatrics and Gerontology (NCGG), Aichi 474-8511, Japan.

View Book :- https://bp.bookpi.org/index.php/bpi/catalog/book/363